Effect of Different Disease-Modifying Therapies on Humoral Response to BNT162b2 Vaccine in Sardinian Multiple Sclerosis PatientsMaristella Pitzalis, Francesco Cucca, Valeria Lodde et al.|Frontiers in Immunology|2021Cited by 57
Reliability of clinical judgment for evaluation of informed consent in mental health settings and the validation of the Evaluation of Informed Consent to Treatment (EICT) scaleNicola Di Fazio, Claudia Dacquino, Donato Morena et al.|Frontiers in Psychology|2024Cited by 7
Effect of different disease-modifying therapies on humoral response to BNT162b2 vaccine in Sardinian multiple sclerosis patientsMaristella Pitzalis, Francesco Cucca, Maria Laura Idda et al.|medRxiv|2021Cited by 6
Cross-sectional analysis of the humoral response after SARS-CoV-2 vaccination in Sardinian multiple sclerosis patients, a follow-up studyMaria Laura Idda, Francesco Cucca, Maristella Pitzalis et al.|Frontiers in Immunology|2022Cited by 6
Implications of disease-modifying therapies for multiple sclerosis on immune cells and response to COVID-19 vaccinationValeria Orrù, Francesco Cucca, Valentina Serra et al.|Frontiers in Immunology|2024Cited by 4